1. Home
  2. Browse Decisions
  3. F.4th
  4. 8 F.4th
  5. 8 F.4th 1331 (2021)
 

ELI LILLY AND CO. v. TEVA PHARMA. INT'L GMBH

2020-1876, 2020-1877, 2020-1878.

8 F.4th 1331 (2021)

ELI LILLY AND COMPANY, Appellant v. TEVA PHARMACEUTICALS INTERNATIONAL GMBH, Appellee.

United States Court of Appeals, Federal Circuit.

Decided: August 16, 2021.

Attorney(s) appearing for the Case

William Barrett Raich, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for appellant. Also represented by Pier DeRoo, Erin Sommers, Yieyie Yang; Sanjay M. Jivraj, Mark Stewart, Eli Lilly and Company, Indianapolis, IN.

William M. Jay, Goodwin Procter LLP, Washington, DC, argued for appellee. Also represented by Elaine Blais, Edwina Clarke, Alexandra Lu, Boston, MA; Natasha Elise Daughtrey, Los Angeles, CA; William Milliken, Deborah Sterling, Sterne Kessler Goldstein & Fox, PLLC, Washington, DC.

Before Lourie, Bryson, and O'Malley, Circuit Judges.

Eli Lilly and Company ("Lilly") appeals from a combined final written decision of the U.S. Patent and Trademark Office ("PTO") Patent Trial and Appeal Board ("Board") holding that the claims of U.S. Patents 8,586,045 ("'045 patent"), 9,884,907 ("'907 patent"), and 9,884,908 ("'908 patent") are not unpatentable as obvious....

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases